Table 3.

Multivariable Linear Regression Analysis for the CAC Progression Rate.

	Model 1 (Clinical RFs + BACS)				Model 2 (Clinical RFs + CACS + BACS)				Model 3 (Clinical RFs + Segment stenosis score + BACS)
	β	95% CI	t	P	β	95% CI	t	p	β	95% CI	t	p
Age, years	−0.015	−0.040–0.011	−1.158	0.250	−0.019	−0.045–0.006	−1.497	0.137	−0.023	−0.047–0.002	−1.858	0.066
Number of parity	0.060	−0.077–0.198	0.871	0.386	0.044	−0.093–0.181	0.641	0.523	0.052	−0.077–0.181	0.806	0.422
Hypertension, n (%)	0.120	−0.237–0.478	0.669	0.505	0.107	−0.246–0.460	0.602	0.549	0.155	−0.181–0.490	0.914	0.363
Current smoking, n (%)	0.196	−0.846–1.237	0.373	0.710	0.174	−0.855–1.203	0.336	0.738	0.259	−0.718–1.236	0.527	0.600
Systolic blood pressure, mmHg	0.006	−0.002–0.014	1.421	0.158	0.006	−0.002–0.014	1.530	0.129	0.003	−0.005–0.011	0.783	0.435
Serum creatinine, mg/dL	0.398	−1.235–2.032	0.484	0.630	0.575	−1.050–2.199	0.702	0.485	−0.049	−1.597–1.500	−0.062	0.950
HbA1c, %	0.493	0.323–0.663	5.736	<0.001	0.497	0.329–0.666	5.855	<0.001	0.431	0.268–0.594	5.241	<0.001
High-density lipoprotein, mg/dL	−0.007	−0.018–0.003	−1.365	0.175	−0.006	−0.017–0.004	−1.192	0.236	−0.006	−0.016–0.004	−1.222	0.224
Low-density lipoprotein, mg/dL	0.002	−0.003–0.006	0.738	0.462	0.001	−0.003–0.005	0.581	0.563	0.001	−0.003–0.005	0.559	0.577
Statin therapy after CCTA	−0.021	−0.445–0.402	−0.100	0.921	−0.051	−0.471–0.368	−0.243	0.809	−0.170	−0.574–0.234	−0.834	0.406
CACS					0.003	0.000–0.007	1.875	0.064
SSS									0.238	0.116–0.361	3.864	<0.001
BACS	0.087	0.009–0.164	2.221	0.029	0.080	0.004–0.157	2.076	0.040	0.079	0.006–0.151	2.146	0.034

Abbreviations are the same as those in Tables 1 and 2.